---
{
  "id": "DOC-12-RELEASE-PRODUCTION-READINESS",
  "title": "Production readiness and launch restrictions",
  "status": "proposed",
  "version": "1.0.0",
  "owner_role": "R14",
  "reviewer_roles": [
    "R13",
    "R17"
  ],
  "scope_ids": [
    "CHN-05",
    "COM-09",
    "INT-07",
    "INT-09"
  ],
  "source_refs": [
    "S00"
  ],
  "assumption_refs": [
    "A01"
  ],
  "updated": "2026-10-28"
}
---

# Production readiness and launch restrictions

Documentation completeness and application readiness are different gates. This specification remains proposed. A partial local/sandbox application, bounded benchmark and actual isolated restore drill now exist; see [implementation readiness](production-readiness-report.md). Real provider certification, full workload qualification, legal approval and production deployment remain absent. Live capabilities default off until their applicable gates pass.

Required launch evidence: exact supported stack/lockfile and reproducible artifacts; accepted requirements/ADRs; complete applicable security/ASVS and WCAG verification; risk-based tests; central performance/capacity results; tenant/cache isolation; financial/property and reconciliation evidence; partner operation certification; contracts/licensing/privacy/retention/region review; approved accounting/financing/payout authority; staffing/on-call/escalation; backup restore/rollback drills; monitored feature rollout and customer content.

R18 assembles evidence by capability/product/channel. A quote-only contract does not authorize purchase; a simulated adapter does not authorize live transmission; PWA tests do not prove native-app delivery. Pending critical evidence keeps the affected operation disabled while safe sandbox boundaries remain testable.

OPS-READY-01 readiness cannot pass with missing required artifact; OPS-READY-02 partial launch lists exact allowed products/channels and retained full-scope backlog; OPS-READY-03 new-sales disable preserves committed servicing. Human signatures are recorded only when actual evidence exists; role-lens agent reviews remain advisory. No deployment action is taken by this documentation task.
